Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.

Predictive behavior within microbial genetic networks. Science (2008) 4.48

Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol (2004) 4.46

A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol (2007) 3.68

Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 2.43

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24

Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol (2008) 2.17

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39

Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics (2014) 1.24

Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immun (2009) 0.97

Investigation of protein export in Bifidobacterium breve UCC2003. Appl Environ Microbiol (2003) 0.96

P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J Immunol (2009) 0.90

Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice. Dig Dis Sci (2008) 0.87

Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol (2012) 0.87

Identification of two-component regulatory systems in Bifidobacterium infantis by functional complementation and degenerate PCR approaches. Appl Environ Microbiol (2003) 0.86

Monitoring healthy metabolic trajectories with nutritional metabonomics. Nutrients (2009) 0.82

Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. BMC Microbiol (2016) 0.81

Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology (2016) 0.76

Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect. Drug Des Devel Ther (2016) 0.75

Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent. Biomed Res Int (2013) 0.75

Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates. Exp Biol Med (Maywood) (2014) 0.75

Screening of Cholesterol-lowering Bifidobacterium from Guizhou Xiang Pigs, and Evaluation of Its Tolerance to Oxygen, Acid, and Bile. Korean J Food Sci Anim Resour (2016) 0.75

From biocontrol to cancer, probiotics and beyond. Bioengineered (2012) 0.75

Colonic lymphoid aggregates in slow transit constipation. Dig Dis Sci (2007) 0.75

Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. NPJ Biofilms Microbiomes (2017) 0.75